• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用延长肽在体外扩增后同时鉴定功能性抗原特异性 CD8 和 CD4 细胞。

Simultaneous Identification of Functional Antigen-Specific CD8 and CD4 Cells after In Vitro Expansion Using Elongated Peptides.

机构信息

Interfaculty Institute for Cell Biology, Department of Immunology, University of Tübingen, 72076 Tübingen, Germany.

Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, 72076 Tübingen, Germany.

出版信息

Cells. 2022 Oct 31;11(21):3451. doi: 10.3390/cells11213451.

DOI:10.3390/cells11213451
PMID:36359847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9654851/
Abstract

Elongated peptides (EPs), containing possibly one or multiple epitope/s, are increasingly used for the screening of antigen-specific CD8 and CD4 cell responses. Here, we present an in vitro protocol that allows the amplification of antigen-specific cells and the subsequent functional analysis of both T cell types using EPs. Known viral-derived epitopes were elongated to 20 mer EPs on the N-, C-, and both termini for HLA class I binders, or on the N- and C- termini for HLA class II binders. With EP stimulation only, the percentage of responding CD8 T cells was dependent on the elongation site of the EP, whereas CD4 T cell responses were completely lost in 22% of the tests performed ex vivo. A short-term amplification step plus the addition of a TLR3 agonist (Poly-ICLC) together with an increased EP concentration improved markedly the detection of CD8 and CD4 T cell reactivities.

摘要

延伸肽(EPs),包含一个或多个表位/抗原,越来越多地用于筛选抗原特异性 CD8 和 CD4 细胞反应。在这里,我们提出了一种体外方案,允许使用 EPs 扩增抗原特异性细胞,并随后对两种 T 细胞类型进行功能分析。已知的病毒衍生表位被延伸成 20 个氨基酸的 EPs,用于 HLA Ⅰ类结合物的 N-、C-和两端,或用于 HLA Ⅱ类结合物的 N-和 C-末端。仅用 EP 刺激,反应性 CD8 T 细胞的百分比取决于 EP 的延伸部位,而在 22%的体外试验中,CD4 T 细胞反应完全丧失。一个短期的扩增步骤加上添加 TLR3 激动剂(Poly-ICLC)和增加 EP 浓度显著提高了 CD8 和 CD4 T 细胞反应性的检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0713/9654851/d2a8f2028b63/cells-11-03451-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0713/9654851/c41499d94a8e/cells-11-03451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0713/9654851/2f6c501a9b3c/cells-11-03451-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0713/9654851/473fb79cb24b/cells-11-03451-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0713/9654851/d51c0963517e/cells-11-03451-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0713/9654851/d2a8f2028b63/cells-11-03451-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0713/9654851/c41499d94a8e/cells-11-03451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0713/9654851/2f6c501a9b3c/cells-11-03451-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0713/9654851/473fb79cb24b/cells-11-03451-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0713/9654851/d51c0963517e/cells-11-03451-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0713/9654851/d2a8f2028b63/cells-11-03451-g005.jpg

相似文献

1
Simultaneous Identification of Functional Antigen-Specific CD8 and CD4 Cells after In Vitro Expansion Using Elongated Peptides.利用延长肽在体外扩增后同时鉴定功能性抗原特异性 CD8 和 CD4 细胞。
Cells. 2022 Oct 31;11(21):3451. doi: 10.3390/cells11213451.
2
The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools.使用重叠肽库同时检测低频抗原特异性 CD4+ 和 CD8+ T 细胞反应。
Cancer Immunol Immunother. 2012 Nov;61(11):1953-63. doi: 10.1007/s00262-012-1251-3. Epub 2012 Apr 11.
3
Detection of EXP1-Specific CD4+ T Cell Responses Directed Against a Broad Range of Epitopes Including Two Promiscuous MHC Class II Binders During Acute Malaria.在急性疟疾期间,检测针对广泛表位(包括两种混合 MHC II 结合肽)的 EXP1 特异性 CD4+ T 细胞反应。
Front Immunol. 2020 Jan 22;10:3037. doi: 10.3389/fimmu.2019.03037. eCollection 2019.
4
Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjects.设计包含免疫原性利什曼原虫蛋白的 HLA Ⅰ类和Ⅱ类限制性表位的多表位肽,并评估治愈的皮肤利什曼病患者中诱导的 CD4+和 CD8+ T 细胞反应。
PLoS Negl Trop Dis. 2020 Mar 16;14(3):e0008093. doi: 10.1371/journal.pntd.0008093. eCollection 2020 Mar.
5
Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.使用细胞因子捕获抗原呈递细胞鉴定 HLA Ⅰ类和 HLA Ⅱ类限制性 T 细胞受体的抗原。
Sci Immunol. 2021 Jan 22;6(55). doi: 10.1126/sciimmunol.abf4001.
6
Determining the breadth of the respiratory syncytial virus-specific T cell response.测定呼吸道合胞病毒特异性 T 细胞应答的广度。
J Virol. 2014 Mar;88(6):3135-43. doi: 10.1128/JVI.02139-13. Epub 2013 Dec 26.
7
Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.鉴定一种ras癌基因肽,其以嵌套形式同时包含CD4(+)和CD8(+)T细胞表位,并通过肽免疫或DNA免疫引发两种T细胞亚群反应。
Cell Immunol. 2000 Nov 1;205(2):73-83. doi: 10.1006/cimm.2000.1712.
8
Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.鉴定具有 CD4+ 和 CD8+ T 细胞表位的混杂 KIF20A 长肽:恶性肿瘤患者中 KIF20A 特异性 CD4+ T 细胞免疫。
Clin Cancer Res. 2013 Aug 15;19(16):4508-20. doi: 10.1158/1078-0432.CCR-13-0197. Epub 2013 May 28.
9
Identification of T cell epitopes by the use of rapidly generated mRNA fragments.通过使用快速生成的mRNA片段鉴定T细胞表位
J Immunol Methods. 2005 Apr;299(1-2):165-75. doi: 10.1016/j.jim.2005.02.004. Epub 2005 Mar 31.
10
Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.人类针对巨细胞病毒(HCMV)蛋白IE1和IE2的CD4+和CD8+T细胞应答的鉴定及HLA四聚体验证
PLoS One. 2014 Apr 23;9(4):e94892. doi: 10.1371/journal.pone.0094892. eCollection 2014.

引用本文的文献

1
An In Vitro Approach to Prime or Boost Human Antigen-Specific CD8 T Cell Responses: Applications to Vaccine Studies.一种启动或增强人抗原特异性CD8 T细胞反应的体外方法:在疫苗研究中的应用。
Vaccines (Basel). 2025 Jul 4;13(7):729. doi: 10.3390/vaccines13070729.
2
The immunopeptidomic landscape of ependymomas provides actionable antigens for T-cell-based immunotherapy.室管膜瘤的免疫肽组学图谱为基于T细胞的免疫治疗提供了可操作的抗原。
Neurooncol Adv. 2025 Jan 16;7(1):vdae226. doi: 10.1093/noajnl/vdae226. eCollection 2025 Jan-Dec.
3
PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development.

本文引用的文献

1
Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.为高风险患者群体设计一种诱导SARS-CoV-2 T细胞的疫苗。
Vaccines (Basel). 2021 Apr 24;9(5):428. doi: 10.3390/vaccines9050428.
2
Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial.针对 RhoC 的疫苗接种可诱导前列腺癌患者产生持久的免疫应答:来自 I/II 期临床试验的结果。
J Immunother Cancer. 2020 Nov;8(2). doi: 10.1136/jitc-2020-001157.
3
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
PCI-DB:一个用于指导下一代基于肽的免疫疗法开发的新型原发性组织免疫肽组数据库。
J Immunother Cancer. 2025 Apr 15;13(4):e011366. doi: 10.1136/jitc-2024-011366.
4
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.基于人类与共生抗原之间的模拟策略开发新型癌症免疫治疗方法。
J Immunother Cancer. 2025 Feb 20;13(2):e010192. doi: 10.1136/jitc-2024-010192.
5
Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling.利用核糖体分析揭示编码T细胞抗原的保守HIV-1开放阅读框。
Nat Commun. 2025 Feb 18;16(1):1707. doi: 10.1038/s41467-025-56773-2.
6
Mesothelin- and nucleolin-specific T cells from combined short peptides effectively kill triple-negative breast cancer cells.源自短肽的间皮素和核仁素特异性 T 细胞可有效杀伤三阴性乳腺癌细胞。
BMC Med. 2024 Sep 18;22(1):400. doi: 10.1186/s12916-024-03625-3.
7
Epitope mapping of outer membrane protein W (OmpW) and laboratory study of an OmpW-derivative peptide.外膜蛋白W(OmpW)的表位作图及一种OmpW衍生肽的实验室研究
Heliyon. 2023 Jul 25;9(8):e18614. doi: 10.1016/j.heliyon.2023.e18614. eCollection 2023 Aug.
SARS-CoV-2 衍生肽定义了异源和 COVID-19 诱导的 T 细胞识别。
Nat Immunol. 2021 Jan;22(1):74-85. doi: 10.1038/s41590-020-00808-x. Epub 2020 Sep 30.
4
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.COVID-19 疾病患者和未接触者体内针对 SARS-CoV-2 冠状病毒的 T 细胞反应的靶标。
Cell. 2020 Jun 25;181(7):1489-1501.e15. doi: 10.1016/j.cell.2020.05.015. Epub 2020 May 20.
5
A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer.一项评估结直肠癌肝转移射频消融后免疫反应的非介入性临床试验。
Front Immunol. 2019 Nov 19;10:2526. doi: 10.3389/fimmu.2019.02526. eCollection 2019.
6
Actively personalized vaccination trial for newly diagnosed glioblastoma.针对新诊断的胶质母细胞瘤的积极个体化疫苗接种试验。
Nature. 2019 Jan;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. Epub 2018 Dec 19.
7
The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.慢性髓性白血病的 HLA 配体组描绘了免疫治疗的新 T 细胞表位。
Blood. 2019 Feb 7;133(6):550-565. doi: 10.1182/blood-2018-07-866830. Epub 2018 Dec 10.
8
The immunopeptidomic landscape of ovarian carcinomas.卵巢癌的免疫肽组学全景。
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9942-E9951. doi: 10.1073/pnas.1707658114. Epub 2017 Nov 1.
9
An immunogenic personal neoantigen vaccine for patients with melanoma.一种用于黑色素瘤患者的免疫原性个人新抗原疫苗。
Nature. 2017 Jul 13;547(7662):217-221. doi: 10.1038/nature22991. Epub 2017 Jul 5.
10
Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient.个性化肽疫苗诱导的免疫反应与一名转移性胆管癌患者的长期生存相关。
J Hepatol. 2016 Oct;65(4):849-855. doi: 10.1016/j.jhep.2016.06.027. Epub 2016 Jul 7.